Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection

About this update from Xiamen Amoytop Biotech Co., Ltd. Class A

Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xiamen Amoytop Biotech Co., Ltd. Class A